Simultaneous study of matrix metalloproteinases, proinflammatory cytokines, and soluble cytokine receptors in the tears of noninfectious corneal ulcer patients

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 252, Issue 9, 2014, Pages 1451-1456

  Sakimoto, Tohru ^a   Ohnishi, Takako ^a   Ishimori, Akiko ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Matrix metalloproteinase; Noninfectious corneal ulcer; Soluble cytokine receptor; Tissue inhibitors of metalloproteinase

Indexed keywords

CYTOKINE; CYTOKINE RECEPTOR; EYE PROTEIN; MATRIX METALLOPROTEINASE; TEAR PROTEINS; TISSUE INHIBITOR OF METALLOPROTEINASE;

CORNEA ULCER; HUMAN; IMMUNOASSAY; LACRIMAL FLUID; METABOLISM; UPREGULATION;

CORNEAL ULCER; CYTOKINES; EYE PROTEINS; HUMANS; IMMUNOASSAY; MATRIX METALLOPROTEINASES; RECEPTORS, CYTOKINE; TEARS; TISSUE INHIBITOR OF METALLOPROTEINASES; UP-REGULATION;

EID: 84925224385     PISSN: 0721832X     EISSN: 1435702X     Source Type: Journal    
DOI: 10.1007/s00417-014-2708-1     Document Type: Article

References (21)

1. Dana MR, Qian Y, Hamrah P (2000) Twenty-five-year panorama of corneal immunology: emerging concepts in the immunopathogenesis of microbial keratitis, peripheral ulcerative keratitis, and corneal transplant rejection. Cornea 19:625–643
2. Sivak JM, Fini ME (2002) MMPs in the eye: emerging roles for matrix metalloproteinases in ocular physiology. Prog Retin Eye Res 21:1–14
3. Gottsch JD, Liu SH, Minkovitz JB, Goodman DF, Srinivasan M, Stark WJ (1995) Autoimmunity to a cornea-associated stromal antigen in patients with Mooren's ulcer. Invest Ophthalmol Vis Sci 36:1541–1547
4. Messmer EM, Foster CS (1999) Vasculitic peripheral ulcerative keratitis. Surv Ophthalmol 43:379–396
5. Yagci A (2012) Update on peripheral ulcerative keratitis. Clin Ophthalmol 6:747–754
6. Jhanji V, Young AL, Mehta JS, Sharma N, Agarwal T, Vajpayee RB (2011) Management of corneal perforation. Surv Ophthalmol 56:522–538
7. Sakimoto T, Shoji J, Sawa M (2003) Active form of gelatinases in tear fluid in patients with corneal ulcer or ocular burn. Jpn J Ophthalmol 47:423–426
8. Shoji J, Inada N, Sawa M (2006) Antibody array-generated cytokine profiles of tears of patients with vernal keratoconjunctivitis or giant papillary conjunctivitis. Jpn J Ophthalmol 50:195–204
9. Clark IM, Swingler TE, Sampieri CL, Edwards DR (2008) The regulation of matrix metalloproteinases and their inhibitors. Int J Biochem Cell Biol 40:1362–1378
10. Kessenbrock K, Plaks V, Werb Z (2010) Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141:52–67
11. Toft-Hansen H, Nuttall RK, Edwards DR, Owens T (2004) Key metalloproteinases are expressed by specific cell types in experimental autoimmune encephalomyelitis. J Immunol 173:5209–5218
12. Matsubara M, Zieske JD, Fini ME (1991) Mechanism of basement membrane dissolution preceding corneal ulceration. Invest Ophthalmol Vis Sci 32:3221–3237
13. Takahashi H, Igarashi T, Fujimoto C, Ozaki N, Ishizaki M (2007) Immunohistochemical observation of amniotic membrane patching on a corneal alkali burn in vivo. Jpn J Ophthalmol 51:3–9
14. Rose-John S, Heinrich PC (1994) Soluble receptors for cytokines and growth factors: generation and biological function. Biochem J 300:281–290
15. Zerler B (1991) The soluble interleukin-2 receptor as a marker for human neoplasia and immune status. Cancer Cells 3:471–479
16. McDermott MF (2001) TNF and TNFR biology in health and disease. Cell Mol Biol 47:619–635
17. Beresford MW (2011) Juvenile idiopathic arthritis: new insights into classification, measures of outcome, and pharmacotherapy. Paediatr Drugs 13:161–173
18. Na KS, Mok JW, Kim JY, Rho CR, Joo CK (2012) Correlations between tear cytokines, Chemokines, and soluble receptors and clinical severity of Dry Eye disease. Invest Ophthalmol Vis Sci 53:5443–5450
19. Bourke E, Cassetti A, Villa A, Fadlon E, Colotta F, Mantovani A (2003) IL-1 beta scavenging by the type II IL-1 decoy receptor in human neutrophils. J Immunol 170:5999–6005
20. Ambati BK, Nozaki M, Singh N, Takeda A, Jani PD, Suthar T, Albuquerque RJ, Richter E, Sakurai E, Newcomb MT, Kleinman ME, Caldwell RB, Lin Q, Ogura Y, Orecchia A, Samuelson DA, Agnew DW, St Leger J, Green WR, Mahasreshti PJ, Curiel DT, Kwan D, Marsh H, Ikeda S, Leiper LJ, Collinson JM, Bogdanovich S, Khurana TS, Shibuya M, Baldwin ME, Ferrara N, Gerber HP, De Falco S, Witta J, Baffi JZ, Raisler BJ, Ambati J (2006) Corneal avascularity is due to soluble VEGF receptor-1. Nature 443:993–997
21. Koch S, Tugues S, Li X, Gualandi L, Claesson-Welsh L (2011) Signal transduction by vascular endothelial growth factor receptors. Biochem J 437:169–183